Trial Profile
A Phase II study of cetuximab in patients who have stage IV colorectal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 21 Jul 2009 Actual patient number (744) added as reported by ClinicalTrials.gov.
- 04 Nov 2008 Actual end date (Aug 2004) added as reported by ClinicalTrials.gov.
- 04 Nov 2008 Primary outcome added as reported by ClinicalTrials.gov.